We’re thrilled to announce that U-Pump has completed its Minimum Viable Product (MVP) — a major step toward transforming insulin therapy for millions living with diabetes.

🚀 What is U-Pump?

U-Pump is the first AI-powered, reusable insulin patch pump, designed for the 80% of insulin-dependent patients who are priced out or underserved by traditional pumps. Our solution is:

• Affordable: Modular cartridges cut treatment costs by up to 60%
• Effortless: OneMove™ Technology allows for quick, painless application
• Precise: Real-time CGM integration (Dexcom, Libre) and AI-assisted dosing

📊 What we've achieved:

✅ MVP completed and currently undergoing dosing precision validation

✅ 435 pre-orders secured, including 131 paid orders totaling $14,000

✅ 2 patents filed, 4 more in development

✅ LTV/CAC ratio of 5.6 | Projected Year 1 revenue: $127M

📌 Next Step: FDA Pre-Submission (Q-Sub)

Within the next few weeks, we’ll submit our FDA 510(k) Pre-Submission to fast-track regulatory clearance and bring U-Pump to market.

💡 Why Invest Now?

We’re solving a $13B+ global problem with a smarter, scalable device backed by a proven team. Early traction and technical validation make this the perfect moment to join our mission.

📣 Be part of the future of diabetes care.

Invest in U-Pump today and help bring affordable, intelligent insulin therapy to those who need it most.